Why the study?
Can gene expression profiling of peripheral blood mononuclear cells distinguish multiple sclerosis patients from healthy controls?
Population
Multiple sclerosis patients and healthy controls
Comparison
Gene expression profiling of peripheral blood… vs Healthy controls
Design
Case-control
Authors
Loading...
May support blood-based MS biomarker development; leaves open clinical utility pending prospective validation.
Can gene expression profiling of peripheral blood mononuclear cells distinguish multiple sclerosis patients from healthy controls?
Gene expression profiling of peripheral blood mononuclear cells can identify molecular markers indicative of multiple sclerosis disease status.
Bomprezzi et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: